These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9697696)

  • 1. Alpha-2 macroglobulin is genetically associated with Alzheimer disease.
    Blacker D; Wilcox MA; Laird NM; Rodes L; Horvath SM; Go RC; Perry R; Watson B; Bassett SS; McInnis MG; Albert MS; Hyman BT; Tanzi RE
    Nat Genet; 1998 Aug; 19(4):357-60. PubMed ID: 9697696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
    Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
    Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the A2M and LRP1 Genes with Alzheimer disease in the Han Chinese.
    Bian L; Yang JD; Guo TW; Duan Y; Qin W; Sun Y; Feng GY; He L
    Biol Psychiatry; 2005 Nov; 58(9):731-7. PubMed ID: 16040006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease.
    Bruno E; Quattrocchi G; Nicoletti A; Le Pira F; Maci T; Mostile G; Andreoli V; Quattrone A; Zappia M
    Neurosci Lett; 2010 Sep; 482(2):112-6. PubMed ID: 20637261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin.
    Saunders AJ; Bertram L; Mullin K; Sampson AJ; Latifzai K; Basu S; Jones J; Kinney D; MacKenzie-Ingano L; Yu S; Albert MS; Moscarillo TJ; Go RC; Bassett SS; Daly MJ; Laird NM; Wang X; Velicelebi G; Wagner SL; Becker DK; Tanzi RE; Blacker D
    Hum Mol Genet; 2003 Nov; 12(21):2765-76. PubMed ID: 12966032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12.
    Luedecking-Zimmer E; DeKosky ST; Chen Q; Barmada MM; Kamboh MI
    Hum Genet; 2002 Oct; 111(4-5):443-51. PubMed ID: 12384789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
    Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
    J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes.
    Reynolds CA; Prince JA; Feuk L; Brookes AJ; Gatz M; Pedersen NL
    Behav Genet; 2006 Mar; 36(2):185-94. PubMed ID: 16402284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD.
    Gibson AM; Singleton AB; Smith G; Woodward R; McKeith IG; Perry RH; Ince PG; Ballard CG; Edwardson JA; Morris CM
    Neurology; 2000 Jan; 54(2):433-8. PubMed ID: 10668708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients.
    Camelo D; Arboleda G; Yunis JJ; Pardo R; Arango G; Solano E; López L; Hedmont D; Arboleda H
    J Neurol Sci; 2004 Mar; 218(1-2):47-51. PubMed ID: 14759632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
    Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
    Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease.
    Poduslo SE; Shook B; Drigalenko E; Yin X
    Am J Med Genet; 2002 Jun; 110(1):30-5. PubMed ID: 12116268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha2 macroglobulin and the risk of Alzheimer's disease.
    Dodel RC; Du Y; Bales KR; Gao F; Eastwood B; Glazier B; Zimmer R; Cordell B; Hake A; Evans R; Gallagher-Thompson D; Thompson LW; Tinklenberg JR; Pfefferbaum A; Sullivan EV; Yesavage J; Alstiel L; Gasser T; Farlow MR; Murphy GM; Paul SM
    Neurology; 2000 Jan; 54(2):438-42. PubMed ID: 10668709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression.
    Blennow K; Ricksten A; Prince JA; Brookes AJ; Emahazion T; Wasslavik C; Bogdanovic N; Andreasen N; Båtsman S; Marcusson J; Nägga K; Wallin A; Regland B; Olofsson H; Hesse C; Davidsson P; Minthon L; Jansson A; Palmqvist L; Rymo L
    J Neural Transm (Vienna); 2000; 107(8-9):1065-79. PubMed ID: 11041282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
    Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
    J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.